U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula Ti
Molecular Weight 47.867
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TITANIUM

SMILES

[Ti]

InChI

InChIKey=RTAQQCXQSZGOHL-UHFFFAOYSA-N
InChI=1S/Ti

HIDE SMILES / InChI

Molecular Formula Ti
Molecular Weight 47.867
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022009s000_ClinPharmR.pdf | https://www.ncbi.nlm.nih.gov/pubmed/18503414

Titanium dioxide, also known as titanium(IV) oxide or titania, is the naturally occurring oxide of titanium, chemical formula TiO 2. When used as a pigment, it is called titanium white, Pigment White 6 (PW6), or CI 77891. Generally it is sourced from ilmenite, rutile and anatase. It has a wide range of applications, from paint to sunscreen to food coloring. When used as a food coloring, it has E number E171. World production in 2014 exceeded 9 million metric tons. Titanium dioxide has excellent ultraviolet (UV) resistant qualities and acts as a UV absorbent. In the pharmaceutical industry, titanium dioxide is used in most sunscreens to block UVA and UVB rays, similar to zinc oxide. It is also commonly used as pigment for pharmaceutical products such as gelatin capsules, tablet coatings and syrups. In the cosmetics industry, it is used in toothpaste, lipsticks, creams, ointments and powders. It can be used as an opacifier to make pigments opaque. The FDA has approved the safety of titanium dioxide for use as a colorant in food, drugs and cosmetics, including sunscreens. However, controversy exists as to the safety of titanium dioxide nanoparticles used in the cosmetics industry, for example in sunscreens. Titanium and zinc oxides may be made into the nanoparticle size (0.2-100 nanometers) to reduce the white appearance when applied topically, but retain the UV blocking properties. Recent studies suggest titanium dioxide nanoparticles may be toxic, although further research is needed.

CNS Activity

Curator's Comment: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022009s000_ClinPharmR.pdf

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: ultraviolet induced damage
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
ANTHELIOS 40

Approved Use

Unknown

Launch Date

2008
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Increased expression of manganese-containing superoxide dismutase in rat lungs after inhalation of inflammatory and fibrogenic minerals.
1994 Mar
Titanium, chromium and cobalt ions modulate the release of bone-associated cytokines by human monocytes/macrophages in vitro.
1996 Dec
Molecular and biomechanical characterization of mineralized tissue by dental pulp cells on titanium.
2005 Jun
Pulmonary exposure to particles during pregnancy causes increased neonatal asthma susceptibility.
2008 Jan
Effects of ultrafine TiO2 particles on gene expression profile in human keratinocytes without illumination: involvement of extracellular matrix and cell adhesion.
2009 Dec 15
Role of air pollution Particulate Matter (PM(2.5)) in the occurrence of loss of heterozygosity in multiple critical regions of 3p chromosome in human epithelial lung cells (L132).
2009 Jun 22
Ultrafine carbon particles down-regulate CYP1B1 expression in human monocytes.
2009 Oct 16
Inhibitor of differentiation 1 (Id1) expression attenuates the degree of TiO2-induced cytotoxicity in H1299 non-small cell lung cancer cells.
2009 Sep 28
Activation of human neutrophils by titanium dioxide (TiO2) nanoparticles.
2010 Apr
Involvement of JNK and P53 activation in G2/M cell cycle arrest and apoptosis induced by titanium dioxide nanoparticles in neuron cells.
2010 Dec 15
Airway exposure to silica-coated TiO2 nanoparticles induces pulmonary neutrophilia in mice.
2010 Feb
Engineered nanomaterials cause cytotoxicity and activation on mouse antigen presenting cells.
2010 Jan 12
Titanium dioxide nanoparticles cause apoptosis in BEAS-2B cells through the caspase 8/t-Bid-independent mitochondrial pathway.
2010 Jun 16
Spleen injury and apoptotic pathway in mice caused by titanium dioxide nanoparticules.
2010 Jun 2
Cellular responses by stable and uniform ultrafine titanium dioxide particles in culture-medium dispersions when secondary particle size was 100 nm or less.
2010 Sep
Ovarian dysfunction and gene-expressed characteristics of female mice caused by long-term exposure to titanium dioxide nanoparticles.
2012 Dec
Nanosized TiO2-induced reproductive system dysfunction and its mechanism in female mice.
2013
Molecular mechanisms of nanosized titanium dioxide-induced pulmonary injury in mice.
2013
Titanium dioxide nanoparticles increase inflammatory responses in vascular endothelial cells.
2013 Apr 5
Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549.
2013 Feb
TiO2, CeO2 and ZnO nanoparticles and modulation of the degranulation process in human neutrophils.
2013 Jul 31
Pulmonary instillation of low doses of titanium dioxide nanoparticles in mice leads to particle retention and gene expression changes in the absence of inflammation.
2013 Jun 15
Improving cytocompatibility of Co28Cr6Mo by TiO2 coating: gene expression study in human endothelial cells.
2013 Sep 6
Sheet-type titania, but not P25, induced paraptosis accompanying apoptosis in murine alveolar macrophage cells.
2014 Oct 1
Patents

Sample Use Guides

Apply evenly 15 minutes before sun exposure. Reapply as needed or after towel drying, swimming, or perspiring. Children under 6 months of age, ask a doctor.
Route of Administration: Topical
For the in vitro studies, the stratum corneum side of the skin was in contact with either the aqueous or oily commercial dispersion of microfine TiO2 (150 μl/cm^2). The dermis side was placed onto a tissue of cellulose soaked with isotonic phosphate buffered saline (PBS) of pH 7.4. Twenty-four hours after application of the dispersion, the PBS was removed from the skin with a dry paper towel. For the in vivo studies, 2 μl cm−2 of the commercial dispersions and the different formulations were applied onto the ventral side of the forearm of a healthy female volunteer. After 45 min, any dispersion or formulation that had not penetrated the skin was also removed with a paper towel. All penetration tests were performed in triplicate.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:08:44 GMT 2023
Edited
by admin
on Fri Dec 15 16:08:44 GMT 2023
Record UNII
D1JT611TNE
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TITANIUM
HSDB   MART.   MI   WHO-DD  
Systematic Name English
TITANIUM [MI]
Common Name English
TITANIUM ELEMENT
Common Name English
TITANIUM [MART.]
Common Name English
TITANIUM METALLICUM
HPUS  
Common Name English
TITANIUM METALLICUM [HPUS]
Common Name English
Titanium [WHO-DD]
Common Name English
TITANIUM [HSDB]
Common Name English
Classification Tree Code System Code
DSLD 2074 (Number of products:31)
Created by admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
NCI_THESAURUS C637
Created by admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
Code System Code Type Description
EVMPD
SUB35397
Created by admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
PRIMARY
FDA UNII
D1JT611TNE
Created by admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
PRIMARY
MERCK INDEX
m10896
Created by admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
PRIMARY Merck Index
DAILYMED
D1JT611TNE
Created by admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
PRIMARY
EPA CompTox
DTXSID3047764
Created by admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
PRIMARY
RXCUI
1305547
Created by admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
PRIMARY RxNorm
CAS
7440-32-6
Created by admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
PRIMARY
HSDB
868
Created by admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
PRIMARY
CHEBI
33341
Created by admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
PRIMARY
ECHA (EC/EINECS)
231-142-3
Created by admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
PRIMARY
NCI_THESAURUS
C95189
Created by admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
PRIMARY
DRUG BANK
DB14160
Created by admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
PRIMARY
PUBCHEM
23963
Created by admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
PRIMARY
MESH
D014025
Created by admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY